Nuyten Dimitry SA 4
4 · Arcus Biosciences, Inc. · Filed Sep 17, 2024
Insider Transaction Report
Form 4
Nuyten Dimitry SA
Chief Medical Officer
Transactions
- Tax Payment
Common Stock
2024-09-15$17.95/sh−5,385$96,661→ 94,933 total
Footnotes (2)
- [F1]Represents the "net settlement" by the Issuer of RSUs previously granted to the reporting person in order to satisfy the applicable tax withholding obligations in connection with the vesting and settlement of such RSUs.
- [F2]Includes 1,123 shares purchased on 5/31/2024 through the Company's Employee Stock Purchase Plan.